AP Biosciences, Inc. (TPEX:6945)
Taiwan
· Delayed Price · Currency is TWD 186.50
0.00 (0.00%)
Apr 29, 2026, 2:00 PM CST
AP Biosciences Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Cash & Equivalents | 970.89 | 1,442 | 278.61 | 1,048 | 527.12 | Upgrade
|
| Short-Term Investments | 200 | 100 | 461.41 | 30.71 | 30 | Upgrade
|
| Cash & Short-Term Investments | 1,171 | 1,542 | 740.02 | 1,079 | 557.12 | Upgrade
|
| Cash Growth | -24.05% | 108.33% | -31.40% | 93.62% | -11.67% | Upgrade
|
| Other Receivables | 42.2 | 36.18 | 24.6 | 14.48 | 0.02 | Upgrade
|
| Receivables | 42.2 | 36.18 | 24.6 | 14.48 | 0.02 | Upgrade
|
| Prepaid Expenses | 8.5 | 3.63 | 1.03 | 0.85 | 6.81 | Upgrade
|
| Total Current Assets | 1,222 | 1,581 | 765.64 | 1,094 | 563.95 | Upgrade
|
| Property, Plant & Equipment | 108.94 | 109.33 | 116.41 | 3.02 | 8.87 | Upgrade
|
| Long-Term Investments | 28.29 | - | - | - | - | Upgrade
|
| Other Intangible Assets | 3.22 | 3.55 | 4.23 | 5.34 | 5.8 | Upgrade
|
| Other Long-Term Assets | 3.29 | 32.8 | 4.48 | 0.78 | 0.73 | Upgrade
|
| Total Assets | 1,365 | 1,727 | 890.76 | 1,103 | 579.35 | Upgrade
|
| Accrued Expenses | 23.26 | 22.64 | 16.72 | 2.48 | 19.96 | Upgrade
|
| Current Portion of Leases | 11.65 | 11.65 | 11.65 | - | - | Upgrade
|
| Other Current Liabilities | 5.89 | 5.37 | 2.51 | 2.04 | 1.19 | Upgrade
|
| Total Current Liabilities | 40.8 | 39.67 | 30.88 | 4.52 | 21.15 | Upgrade
|
| Long-Term Leases | 47.86 | 59.26 | 70.43 | - | - | Upgrade
|
| Other Long-Term Liabilities | 5.57 | 5.46 | 5.35 | - | - | Upgrade
|
| Total Liabilities | 94.22 | 104.38 | 106.65 | 4.52 | 21.15 | Upgrade
|
| Common Stock | 855.73 | 849.87 | 647.48 | 647.48 | 243.74 | Upgrade
|
| Additional Paid-In Capital | 859.15 | 1,196 | 475.92 | 739.72 | 502.1 | Upgrade
|
| Retained Earnings | -444.77 | -422.75 | -339.3 | -288.54 | -187.64 | Upgrade
|
| Comprehensive Income & Other | 1 | -0.66 | - | - | - | Upgrade
|
| Shareholders' Equity | 1,271 | 1,623 | 784.11 | 1,099 | 558.2 | Upgrade
|
| Total Liabilities & Equity | 1,365 | 1,727 | 890.76 | 1,103 | 579.35 | Upgrade
|
| Total Debt | 59.51 | 70.91 | 82.08 | - | - | Upgrade
|
| Net Cash (Debt) | 1,111 | 1,471 | 657.94 | 1,079 | 557.12 | Upgrade
|
| Net Cash Growth | -24.43% | 123.54% | -39.01% | 93.62% | -11.67% | Upgrade
|
| Net Cash Per Share | 13.06 | 19.53 | 10.16 | 20.49 | 23.10 | Upgrade
|
| Filing Date Shares Outstanding | 85.57 | 84.99 | 64.75 | 64.75 | 24.37 | Upgrade
|
| Total Common Shares Outstanding | 85.57 | 84.99 | 64.75 | 64.75 | 24.37 | Upgrade
|
| Working Capital | 1,181 | 1,542 | 734.77 | 1,090 | 542.8 | Upgrade
|
| Book Value Per Share | 14.85 | 19.09 | 12.11 | 16.97 | 22.90 | Upgrade
|
| Tangible Book Value | 1,268 | 1,619 | 779.88 | 1,093 | 552.4 | Upgrade
|
| Tangible Book Value Per Share | 14.82 | 19.05 | 12.04 | 16.89 | 22.66 | Upgrade
|
| Machinery | 33.3 | 39.3 | 36.93 | 31.34 | 30.41 | Upgrade
|
| Construction In Progress | - | - | 28.2 | - | - | Upgrade
|
| Leasehold Improvements | 35.02 | 35.5 | - | 1 | 1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.